本页面由Tiger Trade Technology Pte. Ltd.提供服务

神经分泌生物科学

141.73
+0.02500.02%
成交量:100.63万
成交额:1.43亿
市值:141.31亿
市盈率:33.81
高:144.23
开:141.78
低:141.23
收:141.70
52周最高:160.18
52周最低:84.23
股本:9,970.57万
流通股本:9,800.26万
量比:0.95
换手率:1.03%
股息:- -
股息率:- -
每股收益(TTM):4.19
每股收益(LYR):3.40
净资产收益率:14.96%
总资产收益率:8.66%
市净率:4.70
市盈率(LYR):41.69

数据加载中...

2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

重要事件披露

Form 8-K - Current report
2025/11/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/28

重要事件披露

Form 8-K - Current report
2025/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/30

重要事件披露

Form 8-K - Current report
2025/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/22

重要事件披露

Form 8-K - Current report
2025/05/21

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments